ARCHIVES

NCI Director Andrew von Eschenbach To Resign June 10, Remain As FDA Acting Commissioner.

This article is from The Cancer Letter archive.

Vol. 32 No. 21 | June 2, 2006

Download PDF Visit The Full Archive

Related Articles

Comprehensive Centers Should Emphasize New Treatment, Group Says

July 27, 1979

Senate Kills Plan to Increase Tax On Higher Tar, Nicotine Cigarettes

August 13, 1976

Has To Plan International Meeting On Threat If DNA Biohazards

September 13, 1974

Cooperative Group Leadership Changes: Decosse Heads CCIRC, Hoogstraten Chairmen’s Committee

July 8, 1977

Sondik Named Acting DCPC Deputy Director Sinks Leaving at End Of Month; Edwards Costlow Acting Ads

July 21, 1989

Patient Advocacy: Prostate Cancer Agenda Didn’t Include NCI Plans, Lausner Says

November 29, 1996